Back
Supernus Pharmaceuticals Stock Price Chart
Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
SUPN
Supernus Pharmaceuticals
Last Price:
$32.19
Seasonality Move:
11.26%
7 Day Trial
ALL ACCESS PASS
$
7
This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Supernus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.06 | Buy |
| 20-day SMA: | 31.61 | Buy |
| 50-day SMA: | 32.69 | Sell |
| 200-day SMA: | 33.83 | Sell |
| 8-day EMA: | 31.32 | Buy |
| 20-day EMA: | 31.57 | Buy |
| 50-day EMA: | 32.74 | Sell |
| 200-day EMA: | 33.41 | Sell |
Supernus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.44 | Sell |
| Relative Strength Index (14 RSI): | 53.05 | Buy |
| Chaikin Money Flow: | 272985 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.01 - 32.59) | Buy |
| Bollinger Bands (100): | (32.07 - 37.99) | Sell |
Supernus Pharmaceuticals Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Supernus Pharmaceuticals Stock
Is Supernus Pharmaceuticals Stock a Buy?
-
Supernus Pharmaceuticals share price is 32.22 while SUPN 8-day simple moving average is 31.06, which is a Buy signal.
-
The stock price of SUPN is 32.22 while Supernus Pharmaceuticals 20-day SMA is 31.61, which makes it a Buy.
-
Supernus Pharmaceuticals 50-day simple moving average is 32.69 while SUPN share price is 32.22, making it a Sell technically.
-
SUPN stock price is 32.22 and Supernus Pharmaceuticals 200-day simple moving average is 33.83, creating a Sell signal.
SUPN Technical Analysis vs Fundamental Analysis
Buy
54
Supernus Pharmaceuticals (SUPN)
is a Buy
Is Supernus Pharmaceuticals a Buy or a Sell?
-
Supernus Pharmaceuticals stock is rated a BuyThe current Supernus Pharmaceuticals [SUPN] share price is $32.22. The Score for SUPN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Supernus Pharmaceuticals Stock Info
Market Cap:
1.8B
Price in USD:
32.22
Share Volume:
356.1K
Supernus Pharmaceuticals 52-Week Range
52-Week High:
40.28
52-Week Low:
25.53
Buy
54
Supernus Pharmaceuticals (SUPN)
is a Buy
Supernus Pharmaceuticals Share Price Forecast
-
What is the Supernus Pharmaceuticals stock price today?The Supernus Pharmaceuticals stock price is 32.22 USD today.
-
Will SUPN stock go up or go down?Supernus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Supernus Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals is not overvalued.
Is Supernus Pharmaceuticals Stock a Buy?
-
Supernus Pharmaceuticals share price is 32.22 while SUPN 8-day exponential moving average is 31.32, which is a Buy signal.
-
The stock price of SUPN is 32.22 while Supernus Pharmaceuticals 20-day EMA is 31.57, which makes it a Buy.
-
Supernus Pharmaceuticals 50-day exponential moving average is 32.74 while SUPN share price is 32.22, making it a Sell technically.
-
SUPN stock price is 32.22 and Supernus Pharmaceuticals 200-day simple moving average is 33.41, creating a Sell signal.
Fundamental Analysis of Supernus Pharmaceuticals
Is Supernus Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.89 per share, and an increase next year of $0.56 per share.
Technical Analysis of Supernus Pharmaceuticals
Should I short Supernus Pharmaceuticals stock?
-
SUPN Moving Average Covergence Divergence (MACD) indicator is -0.44, suggesting Supernus Pharmaceuticals is a Sell
-
Supernus Pharmaceuticals Relative Strength Index (RSI) is 53.05, which suggest Supernus Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Supernus Pharmaceuticals is (31.01 - 32.59), which suggest Supernus Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Supernus Pharmaceuticals is (32.07 - 37.99), which suggest Supernus Pharmaceuticals is a Sell
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.